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Produced by multiple diatom species across
several genera, most notably Pseudo-nitzschia,
the toxin domoic acid (DA) is responsible for
human poisonings (Wright et al. 1989),
which are clinically diagnosed as amnesic
shellfish poisoning (ASP) (Perl et al. 1990).
Planktivorous ﬁsh are primary vectors for DA
in marine food webs, exposing several marine
birds and mammals to this neurotoxin
(Lefebvre et al. 1999; Scholin et al. 2000;
Work et al. 1993). DA is structurally related
to kainic acid, a subgroup of the neuro-
transmitter glutamate family, and therefore
activates ionotropic AMPA and kainate sub-
types of glutamate receptors (Slevin et al.
1983). Receptor activation leads to glutamate
release and coincident glutamate-NMDA
(N-methyl-D-aspartate) receptor–mediated
induction of immediate response genes (Peng
et al. 1994; Ryan et al. 2005) and excito-
toxicity (Novelli et al. 1992).
Consistent with symptoms observed in
humans (Teitelbaum et al. 1990), similar indi-
cators of DA exposure have been repeatedly
documented in mice, rats, and monkeys
(Tasker et al. 1991; Tryphonas et al. 1990a,
1990b). Of particular note are the behavioral
manifestations of seizures, including stereo-
typic scratching, tremors, and tonic–clonic
seizures, which have been used to quantitate
toxicity scores (Tasker et al. 1991). In addition
to behavioral symptoms, DA exposure has
been reported to cause neuroexcitation and
extensive degeneration in brain tissues (Peng
et al. 1994; Scallet et al. 1993), along with
learning and memory deficiency in humans
and experimental animals (Clayton et al.
1999; Petrie et al. 1992; Sutherland et al.
1990; Teitelbaum et al. 1990). The pyrami-
dal cells in the amnion horn region of the
hippocampus exhibit the most damage, with
DA also prominently affecting the septum
and olfactory bulb (Colman et al. 2005;
Scallet et al. 1993). The pathways through
the hippocampus, which are responsible for
learning and spatial memory, are highly
prone to seizures (Ramsdell 2007). Thus, the
susceptibility for seizures in areas of the brain
responsible for learning and memory assimila-
tion allows for the overlap in investigative
models regarding the role of environmental
toxicants on epilepsy, as well as on memory
and learning impairments.
Subsequent to DA toxicity characteriza-
tion in adult animals, substantial research has
examined developmental toxicity, in large
part to better understand through laboratory
studies the high levels of DA toxicity
observed in pregnant California sea lions
(Brodie et al. 2006; Gulland et al. 2002).
Susceptibility to DA has been characterized
both in prenatal and postnatal rats and mice.
Postnatal rats are highly sensitive to DA,
responding with seizure behavior to doses
40 times lower per body weight than adults
(Xi et al. 1997). As the animals mature
through postnatal life, the outward manifesta-
tion of seizure behavior changes, which is
likely a reﬂection of growth surge associated
with migration of new neuronal pathways
and synaptogenesis (Doucette et al. 2000,
2004). Concurrently, the maturation of renal
function correlates with the decrease in sus-
ceptibility of neonates to DA as they age. In
addition, although an effective dose of DA is
present in milk from exposed lactating rats,
parental transfer of toxin by lactation remains
well below symptomatic doses due to low oral
adsorption (Maucher and Ramsdell 2005).
Prenatal rats are susceptible via in utero
exposure to DA, with symptoms usually
showing up later during postnatal life.
In utero exposure of gestational day (GD) 13
mice to DA decreases the threshold to DA-
induced seizures by postnatal day (PD) 10
(Dakshinamurti et al. 1993). In rats it leads to
a reversal in the normal sex-based difference in
learning and decreases the threshold to scopo-
lamine-induced memory impairment as juve-
niles (Levin et al. 2005). These later effects
appear speciﬁc to the prenatal exposure, as rats
treated at PD0–PD1 did not show these
deficits as juveniles (Levin et al. 2006).
Neurogenesis in mice and rats occurs during
the second half of gestation (GD12–GD20),
as the brain growth spurt and synaptogenesis
is postnatal (Dobbing and Sands 1979). This
indicates that neurogenesis represents the sen-
sitive window of exposure to DA during
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BACKGROUND: Domoic acid (DA) is a neurotoxin produced by diatoms of the genus Pseudo-
nitzschia that targets the limbic system to induce tonic–clonic seizures and memory impairment.
In utero DA exposure of mice leads to a reduction in seizure threshold to subsequent DA exposures
in mid-postnatal life, and similar studies have shown neurotoxic effects in rats that were delayed
until adolescence.
OBJECTIVE: We used in ovo microinjection of zebraﬁsh (Danio rerio) to characterize the effect of
embryonic exposure of DA on seizure-inducing agents later in life as an alternative species model to
screen environmental contaminants that might induce a fetal-originating adult disease.
METHODS: Embryos were microinjected within hours of fertilization to DA concentrations ranging
from 0.12 to 1.26 ng/mg egg weight. Seven days later, the larval animals were characterized for sensi-
tivity to the chemical convulsant pentylenetetrazole (PTZ), an agent that is well-deﬁned in laboratory
rodents and, more recently, in zebraﬁsh.
RESULTS: In ovo DA exposure, most signiﬁcantly at 0.4 ng/mg, reduces the latency time until ﬁrst
PTZ seizure in larval ﬁsh and increases the severity of seizures as determined by seizure stage and
movement parameters. The interaction between in ovo DA exposure and PTZ caused seizure
behaviors to individually asymptomatic doses of PTZ (1.0 and 1.25 mM) and DA (0.13 and
0.22 ng/mg).
CONCLUSION: These studies demonstrate that in ovo exposure to DA reduces the threshold to
chemically induced seizures in larval ﬁsh and increases the severity of seizure behavior in a manner
that is consistent with in utero studies of laboratory rodents.
KEY WORDS: Danio rerio, domoic acid, EthoVision, pentylenetetrazole, seizures, zebraﬁsh. Environ
Health Perspect 115:1547–1552 (2007). doi:10.1289/ehp.10344 available via http://dx.doi.org/
[Online 2 August 2007]development. Research characterizing the
enhanced sensitivity to convulsant and amnes-
tic drugs expressed later in life as result of
in utero exposure is part of an emerging disci-
pline known as the fetal basis to adult disease,
which predicts a peak impact in the earlier
in utero development for increased susceptibil-
ity to dysfunction later in life (Heindel 2005).
Zebrafish are increasingly being used as
models for neurotoxicity, and the accessibility
of the embryos to manipulation and observa-
tion are ideal for developmental studies (Ton
et al. 2006). DA symptomatology in early
development has been investigated in zebraﬁsh
embryos and larvae, and has also been found to
emulate symptoms characteristic of rodents.
When eggs are injected with DA, within hours
of fertilization and before the onset of the ﬁrst
phase of neurogenesis, embryos exhibit marked
tonic–clonic type convulsions at 2 days post-
fertilization (dpf) and constant rapid pectoral
ﬁn motion beginning at 5 dpf (Tiedeken et al.
2005). Distinct seizure patterns have also been
characterized in 7-dpf larval zebraﬁsh exposed
by bath to the seizure-inducing agent pentyl-
enetetrazole (PTZ) (Baraban et al. 2005). PTZ
is a competitive antagonist of the GABAA
(gamma-aminobutyric acid type A) receptor,
binding to the picrotoxin site of the channel
and acting via an allosteric interaction on the
channel (Huang et al. 2001; Ramanjaneyulu
and Ticku 1984; Rehavi et al. 1982). Its action
on the GABAA receptor causes blockage of
chloride conductance and formation of
inhibitory postsynaptic potentials, which
increases glutamatergic excitability (Macdonald
and Barker 1978). In larval zebrafish, three
stages of seizure activity have been character-
ized and validated using electrophysiologic
and pharmacologic analysis. The ﬁrst stage is
deﬁned as a general overall increase in activ-
ity, followed by rapid whirlpool-like swim-
ming in the second stage, and concluding
with full body convulsions in stage three
(Baraban et al. 2005).
In this study we used zebraﬁsh embryos as
an alternate species to quantify the persistent
effects of early-life exposure to DA. By using
PTZ as an acute chemical convulsant, well-
deﬁned seizure behaviors have been analyzed
in larval fish exposed to DA prior to neuro-
genesis. The correspondence of this study to
parallel studies in rodents indicates that
results in microinjected zebraﬁsh embryos can
be more widely applied to screen for environ-
mental contaminants that may induce a fetal-
originating adult disease.
Materials & Methods
Zebrafish. Thirty male and female zebrafish
(Danio rerio) of AB wild-type strain were
obtained from Zebraﬁsh International Resource
Center (ZIRC; Eugene, OR) and allowed to
breed at random for embryo production. Fish
were kept on a 14 hr light:10 hr dark cycle in a
recirculating aquarium rack system (Aquatic
Habitats, Apopka, FL); water conditioning and
environmental quality was maintained accord-
ing to the manufacturer’s instructions and The
Zebrafish Book (Westerfield 2000). Utmost
care was used to insure that the animals were
treated humanely, and in cases where distress
could not be alleviated, the animals were
euthanized. Zebrafish were fed twice daily
with Zeigler Adult Zebrafish Diet (Aquatic
Habitats) and on afternoons before breeding
the diet was supplemented with live Artemia.
Breeding inserts were placed in tanks with a
plastic plant to collect fertilized eggs (embryos)
in the morning. The embryos were removed
from the bottom of the tank within the first
hour of light, and washed with sterile water.
DA in ovo microinjection. DA, along with
all other reagents, was purchased from Sigma
Chemical (St. Louis, MO). The DA was resus-
pended in sterile phosphate-buffered saline
(PBS) to a stock concentration of 10 mg/mL.
Concentrations were diluted in PBS in prepa-
ration for a 2.4-nL injection to create 0.126,
0.22, 0.40, 0.71, and 1.26 ng DA per embryo
(1.4 mg wet weight). Concentrations were
determined on the basis of previous work by
Tiedeken et al. (2005).
Healthy embryos between 1K-cell and
high-oblong cell stages, which occurs around
3–4 hr postfertilization (hpf) depending on
temperature conditions (Kimmel et al. 1995),
were aligned in troughs imbedded in an
agarose plate as described in The Zebraﬁsh Book
(Westerfield 2000). Each plate, one for con-
trols and one for DA injections, was doused
with 12.5% Hanks solution (Westerfield
2000) to submerge embryos. All injection pro-
cedures were observed using a Leica MZ 12
stereomicroscope (Leica Microsystems Inc.,
Bannockburn, IL). A pulled (P-87; Sutter
Instrument Co., Navato, CA) and beveled
(BV-10; Sutter Instrument Co.) alumino-
silicate filament micropipette (o.d. 1 mm;
Sutter Instrument Co.) was filled with a
known DA concentration using a microloader
pipette tip (Eppendorf North America,
Westbury, NY) and placed in a micro-
manipulator (MO-150; Narashige Group,
Long Island, NY). A nitrogen gas pico-injector
(PLI-100; Harvard Apparatus, Holliston, MA)
was calibrated to consistently produce 2.4 nL
of injection material.
After injection, embryos were removed
from the plates and transferred to petri dishes
(Corning Life Sciences, Acton, MA) with E3
media (Brand et al. 2002), which was replaced
daily following removal of nonviable embryos.
Embryos hatched around 3 dpf and the larvae
were raised to 7 dpf in a 28°C incubator, with
frequent observational monitoring for DA
toxicity. On the sixth day, media was slowly
changed to Ringers solution (Westerfield
2000) to allow for the embryos to acclimate
before trials.
PTZ challenges. For each DA dose,
including vehicle-injected and noninjected,
7-day-old larvae were transferred to individual
wells of 96-well plates (Costar 3610; Corning
Life Sciences) with 50 µL fresh Ringers solu-
tion and allowed to acclimate for a few hours.
Plates were arranged so that at least 10 larvae
were available for each PTZ dose. Noticeable
DA symptomology, pectoral ﬁn movements,
and deformities were noted at this time. The
plate was placed on the white light box at the
bottom of a Tracksys Tower Filming system
(Tracksys Ltd., Nottingham, UK), and a baf-
ﬂe was lowered to reduce ambient light. The
tower was connected to a computer running
EthoVision Pro 3.1 behavioral tracking soft-
ware (Noldus Information Technology Inc.,
Leesburg, VA). A 3-min baseline trial was
tracked using EthoVision and simultaneously
recorded using an MPEG encoder (MPEG
Pro EMR100; Canopus, San Jose, CA). The
medium was replaced with one of eight con-
centrations of PTZ (0, 1, 1.25, 2.5, 5, 10, 15,
or 25 mM) dissolved in Ringers solution. The
response was recorded for a total of 20 min
with an additional 3-min EthoVision trial
occurring after 15 min of exposure had lapsed.
After observations, all subjects were eutha-
nized with a lethal concentration of MS-222
Tricaine (ethyl-3-aminobenzoate methane-
sulfonate salt; Sigma Chemical).
Analysis. DA-induced morphologic and
behavioral differences were compared using
recorded images from a Sony RGB camera
(DXC-390; Sony Corporation, Tokyo, Japan)
attached to the Leica stereomicroscope.
Recordings of the larvae after the addition of
PTZ were reviewed for behavioral changes and
seizures. Time to reach the first definitive
stage II seizure (seizure latency) was also
noted. Because the viability of the larvae var-
ied due to the dose of DA, sample size varied
from 12 to 40. We obtained the distance
moved and the mobility parameters from
EthoVision tracking program analysis, and
baseline parameters were subtracted out before
calculation of statistics. Because of the time-
dependent nature of the trials, those individu-
als who did not track properly were excluded;
however, we used a minimum of 10 individu-
als per DA/PTZ combination in all calcula-
tions. Two-way analysis of variance (ANOVA)
followed by Bonferroni means comparison test
(Prism version 4; GraphPad Software Inc.,
San Diego, CA) were used to analyze the com-
pounding effects of both DA and PTZ
responses on the larval ﬁsh.
Results
Acute embryonic response to DA. We assessed
the acute response to DA microinjection for the
embryonic period, concluding with hatching
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Embryos exposed in ovo with low doses of
0.126 and 0.22 ng/mg DA displayed no visual
symptomatic behavioral responses to the toxin.
Two days after injection (2 dpf), members of
the 0.4-, 0.71-, and 1.26-ng/mg groups exhib-
ited DA-induced convulsive behavior that
endured for 12–24 hr. As described previously,
the behavior resembled tonic–clonic convul-
sions manifested as a whole-body contraction
with a shuddering motion (Tiedeken et al.
2005). Each contraction lasted approximately
3–5 sec, and the percentage convulsing
increased with dose. In addition, the higher
dose groups had individuals with spinal defor-
mities and incessant pectoral fin motions
which were observed as early as 4 dpf and per-
sisted through the conclusion of the experi-
ment at 7 dpf. Many larval individuals in the
two highest DA cohorts, especially those suffer-
ing from the spinal deformities, exhibited an
absence of touch response and an overall
inability to move. The percentage of sympto-
matic individuals and severity of DA toxicity
increased proportionately with dose. In all
analyses, the vehicle-injected controls and the
noninjected controls exhibited asymptomatic
behavior, and minor differences arising in PTZ
trials were determined to be insignificant
(p > 0.05).
Sustained larval response to DA. PTZ
seizure characterization. A stage II seizure to
PTZ in zebraﬁsh consists of an easily identiﬁ-
able, rapid, whirlpool swimming motion
(Figure 1A), which is clearly distinguishable
from the first stage of generalized motion
(Baraban et al. 2005). The 7-dpf larvae with
prior DA exposure all showed an increased
seizure response corresponding to the concen-
tration of PTZ, ranging from 1 to 25 mM in
bathing solution. Embryos exposed to a
midrange effective dose of 5 mM PTZ
responded with increased severity to the seizure
inducing agent as in ovo DA dose increased
(Figure 1B). Larvae that were immobilized
(from the 1.26 ng/mg DA cohort) responded
to the PTZ with whole-body (head touches
tail) contractions, severe tremors, and/or an
increase of pectoral fin motion allowing for
slow spinning movements (Figure 1C). Across
all DA and PTZ combinations, individuals
showed a writhing motion in addition to
deﬁned seizure stages. This behavior was not
observed in larvae without in ovo DA exposure,
and no seizure activity was noted in the
absence of PTZ (Ringer’s solution), regardless
of DA exposure. These writhing and spinning
movements exhibited at the higher in ovo DA
doses (≥ 0.4 ng/mg) impaired some of the
embryos from reaching a discernable stage II
seizure behavior, and many went directly into
stage III (convulsive) activity. At lower doses of
PTZ (< 5 mM), increasingly more larvae were
exhibiting a stage II response to PTZ within
the observation time (Figure 2). At concentra-
tions of PTZ > 5 mM, all embryos exhibited a
response, regardless if it was a recognizable
stage II seizure.
Analysis of seizure latency. The time
required between PTZ exposure and initiation
of the first stage II seizures in the larvae was
measured for seizure latency. In control ﬁsh,
the seizure latency was approximately 800 sec
for 2.5 mM PTZ to about 150 sec for 25 mM
PTZ. All larvae exposed in ovo to DA showed
a time reduction in stage II seizure latency,
and at high PTZ concentrations (> 10 mM) a
stage II seizure was observed within the first
60 sec (Figure 3). Commencing with the
0.22-ng/mg group, DA-treated embryos
reached a stage II seizure activity at the lowest
PTZ dose (1 mM), a dose that elicited no
PTZ induced seizures in DA-exposed zebrafish
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Figure 1. EthoVision tracks (3-min duration) recorded before (baseline) and 15 min after PTZ addition. Lines
show the track of fish movement. (A) Control (0.0 ng/mg DA) larvae exposed to 0, 2.5, and 25 mM PTZ,
exhibiting seizure behaviors; no control larvae exhibited Stage III convulsions only. (B) Larvae demonstrat-
ing increased seizure activity across increasing DA concentrations when exposed to 5 mM PTZ. (C) Track
examples of differences in PTZ (25 mM) response resulting from embryonic exposure to various prior DA
doses: a) 1.26 ng/mg DA, stage III convulsions only; b) 1.26 ng/mg DA, increased movement originating
from increased pectoral fin response only; c) 0.71 ng/mg DA, increased convulsive movement;
d) 1.26 ng/mg DA, circular motion resulting from spinal deformities; and e) 0.4 ng/mg DA, increased move-
ment in a similar pattern to, but without completing, a deﬁned stage II seizure.
Control Stage 1 Stage 2 A
B
C
0 ng/mg DA 0.2 ng/mg DA 0.4 ng/mg DA 1.26 ng/mg DA
abc d e
Baseline
PTZ
0 mM PTZ 2.5 mM PTZ 25 mM PTZ
Figure 2. Percentage of individuals across DA doses exhibiting a behavioral response to exposure to PTZ
within 20 min observation. Fish that exhibited a writhing motion or convulsive-only motion without a deﬁn-
able whirlpool action were grouped as other movements. “Deformities” include the percentage of fish
whose physical deformities from DA prohibited them from exhibiting stage II seizures. The number of
0.13-ng/mg DA-exposed larvae responding is comparable to 0 ng/mg and has been omitted. PTZ doses
> 5 mM exhibited 100% response across all DA doses (data not shown).
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PTZ (mM)seizure response in the control groups. The
in ovo 1.26 ng/mg DA exposure group also
exhibited a behavioral response to 1 mM PTZ
within 100 sec of exposure, although it was
indefinable as a stage II seizure. Significant
time reductions of seizure latencies were also
noted across other dose combinations
(Figure 3). Even the lowest DA treatment
(0.13 ng/mg) showed a signiﬁcant reduction
in time (p < 0.05) at 1.25 and 2.5 mM PTZ
concentrations (data not shown). Although
not included in this analysis, those in ovo
exposed embryos that did not have a deﬁned
stage II reaction still showed a unique motion
response to PTZ within the ﬁrst 200 sec. This
may contribute to the insignificant decrease
from in ovo DA exposure at PTZ levels of
≥ 10 mM because a larger percentage went
straight into a stage III seizure or did not
exhibit a distinguishable seizure.
Analysis of distance moved. Stage I,
defined as a generalized increase in activity,
and stage II seizures both exhibit increased
movement around the well, whereas stage III
seizures (stationary convulsions) exhibit a
reduction in movement. When tracked with
EthoVision after 15-min immersion in various
concentrations of PTZ, DA-exposed cohorts
(0.22 and 0.4 ng/mg) showed a significant
increase (p < 0.01) in distance moved. At bath
concentrations of PTZ up to 5 mM, larvae
that had been exposed in ovo to doses as low as
0.22 ng/mg DA traveled at least twice the dis-
tance as vehicle-microinjected embryos
(Figure 4). As the larvae exposed to higher
in ovo doses of DA progressed through the
stages of seizures faster, they reached a stage III
seizure sooner than the controls. EthoVision
responded by tracking less distance moved at
these levels. High DA doses showed signiﬁcant
(p < 0.05) decreases in distance moved when
exposed to 15 and 25 mM PTZ. Members of
the 1.26-ng/mg DA cohort traveled 5 times
the distance of any other group when exposed
to 1 mM PTZ, despite never exhibiting a
deﬁnable stage II seizure.
Analysis of larval mobility. The mobility
parameter of the EthoVision software is able
to detect distance traveled along with station-
ary movement of the individual. Stage III
seizures, a convulsive behavior, show no dis-
tance movement but do exhibit stationary
body movement. Embryos treated with DA
showed a signiﬁcant increase in the duration
of time spent in a strongly mobile state, a
measurement that occurred mostly at stage II
(Figure 5). Members of the lowest dose
cohort of DA (0.13 mg/kg) showed a signiﬁ-
cant increase (p < 0.05) in mobility duration
at 15 mM PTZ; this parameter incorporates
not only stage II movement but stage III.
Other doses of PTZ for this 0.13-ng/mg DA
cohort did not clear a statistical cutoff
(p < 0.05) for increased mobility but did show
a signiﬁcant decrease in duration of immobil-
ity (p < 0.01), indicating that the fish had
increased overall activity (data not shown) at
1.25, 2.5, and 5 mM PTZ. Larvae that were
exposed in ovo to 0.4 ng/mg DA showed the
greatest increase in mobility with exposure to
5 and 10 mM PTZ. The fish in this cohort
also spent signiﬁcantly (p < 0.001) more time
in a strongly mobile state at 5 and 10 mM
PTZ as well as 2.5 mM PTZ (p < 0.01)
(Figure 5). Although the distance moved did
not signiﬁcantly increase (p > 0.05) compared
with the vehicle-exposed group, the members
of the highest DA group (1.26 ng/mg)
showed a significant (p < 0.001) decrease in
duration of strong mobility and an increase in
mobility to higher PTZ doses, thereby
indicating that these larvae were undergoing
convulsive motions. Because of the large vari-
ability between individuals, greater statistical
differences may come to fruition with addi-
tional trials.
Discussion
The present study demonstrates that in ovo
exposure to DA increases the susceptibility of
larval zebraﬁsh to the seizure-inducing agent
PTZ. Furthermore, effects of early-life DA
exposure were observed after exposure to non-
symptomatic doses of PTZ, demonstrating
that DA toxicity can be unnoticeable until pro-
voked by a heterologous agent. Larval fish
exposed to DA as embryos also showed a
signiﬁcantly greater seizure response to sympto-
matic doses of PTZ. This was clearly demon-
strated through increased movements and
behavioral responses. DA exposure allowed for
an increased response, both in number of ani-
mals responding and in time to reach a
response within the observational window of
20 min. Although only stage II whirlpool
motion activity was scored, there was an overall
change of behavior noted in the DA-exposed
groups. Many larvae, especially at higher DA
doses, lacked touch response and movement;
however, exposure to PTZ in these animals led
to an immediate motion response. These
responses ranged from simple increased move-
ment (stage I) to immediate stage III seizures
without advancement through the typical pro-
gression of seizure behavioral stages. Overall,
these responses provide evidence that DA
causes an early alteration in the potential
excitability of seizure-prone neuronal pathways
in larval zebraﬁsh.
Although the time frame for neurodevelop-
ment in zebrafish is rapid compared with
mammalian models, the delineation of major
brain regions and their developmental plan is
well conserved. In zebraﬁsh, the brain is appar-
ent toward the end of the gastrula period
(9 hpf), which is > 5 hr after DA was micro-
injected into the yolk sac. By the mid-
pharyangula period (28 hpf), the major
forebrain regions are in place, including the
diencephalon (comprised of dorsal thalamus
Tiedeken and Ramsdell
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Figure 3. Amount of time (mean ± SE) for a definable stage II seizure after
immersion in PTZ media. 
aNo fish had a stage II response at this dose. bAll fish in this group showed a motion
response but were unable to complete a deﬁnitive stage II seizure. *p < 0.05, **p < 0.01,
and #p < 0.001 compared with control.
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##and ventral hypothalamus) and the telen-
cephalon (comprised of the pallium and lateral
division) (Mueller and Wullimann 2003).
These areas have shown correspondence to the
mammalian hippocampus and subpallium
(Rodriguez et al. 2002). Although these regions
are conserved, the anamniotic zebrafish—
unlike amniotic mammals—undergo two dis-
tinct processes of neurodevelopment that are
needed to accommodate the early developing
larval life form. This results in an early phase of
neurogenesis that occurs within the first day
(16 hpf) to form the simple larval brain plan,
and a second wave following hatching, com-
mencing around 48 hpf. This second wave of
neurogenesis, via migration of neurons from
the ventricular surface of the larval brain, will
override much of the circuitry created in
embryonic development (Mueller and
Wullimann 2003). Although all the elements
of neuronal development are present in the
zebrafish model, the difference in processes
may vary the comparison to rodent models.
DA administered in ovo induces acute
neurotoxic effects as the brain matures and
gains responsiveness to the toxin. Effects of DA
do not become apparent until tonic–clonic
convulsions begin at the end of the pharyan-
gela phase (2 dpf) (Tiedeken et al. 2005). This
indicates that the early neural network of the
larval brain is responsive to this glutamatergic
convulsant. Interestingly, this effect is transient
and lasts only until onset of the hatching
phase, about 6 hr later. However, other neuro-
logic effects appear after hatching, including
stereotypic-like pectoral ﬁn ﬂapping beginning
at 5 dpf and, at higher doses, a loss of touch
response. The 7-dpf larvae, which have com-
pleted the ﬁnal absorption of the yolk sac, have
been well characterized for seizure response to
PTZ by behavioral, electrographic, and phar-
macologic criteria and were determined to
develop multiple phases of seizure activity
mediated by glutamatergic:GABAergic neuro-
transmitter systems (Baraban et al. 2005). The
PTZ larval symptomology is comparable with
symptoms observed in postnatal and adult
rodents exposed to the convulsive agent.
We have extended our acute studies of
in ovo DA exposure in zebrafish to examine
the persistent effects of DA later in life by
examining the response to the chemical con-
vulsant PTZ. PTZ is very well characterized
as a convulsant and is a well-established acute
seizure model in rats and mice to investigate
pharmaceuticals that may control seizure sus-
ceptibility (White et al. 1995). The studies
presented here show that zebrafish demon-
strate similar persistent susceptibility to
excitotoxins, as has been determined in
rodents. When pregnant mice are exposed to
an asymptomatic dose of DA on GD13, the
postnatal offspring show no evidence of spon-
taneous seizures, yet demonstrate increasing
irregularities in electroencephalogram record-
ings in postnatal life (Dakshinamurti et al.
1993). The postnatal mice, however, did
show a reduced threshold to DA-induced
seizures compared with mice that had no
prior in utero exposure. Like the larval
zebraﬁsh exposed to DA in ovo, the neonatal
mice exposed to DA in utero exhibited a
reduction in seizure latency and greater
seizure activity (Dakshinamurti et al. 1993).
The effects of in utero DA exposure in mice
were not evident until postnatal life; however,
acute neurotoxic effects in neonates cannot be
discounted. By contrast, acute effects of in ovo
DA exposure in zebraﬁsh are readily apparent
before hatching because of easily visualized
embryogenesis, allowing for identiﬁcation of
doses causing transient effects during develop-
ment that may not be readily apparent in the
mouse model. Observation of early seizure
behavior in ovo allows for establishment of
threshold DA dose values relative to neuro-
logic development in the embryo.
In the mouse model, effects were analyzed
through neuronal histology, which showed no
evident altered morphology of the hippocam-
pus on the first postnatal day, yet began to
appear midway through the postnatal period
(PD14) (Dakshinamurti et al. 1993). This
time corresponds to the postnatal growth surge
in rodents, which includes apoptosis, migra-
tion, and synaptogenesis of the brain tissue.
The neuronal damage in the mouse hippocam-
pus was associated with increased chemical
excitability, as indicated by an increased ratio of
glutamate:GABA in the brain and receptor
density determined by increased kainic acid
binding sites (Dakshinamurti et al. 1993). The
increased sensitivity to PTZ seizures in zebraﬁsh
is consistent with an action of DA to increase
the chemical excitability of the balance between
glutamate and GABA neurotransmitters.
Neurogenesis in the mouse hippocampus
begins at GD13, and in utero exposure to DA
at this time suggests that alteration in neuro-
genesis may ultimately lead to organization,
which promotes excitatory (glutamatergic)
overinhibitory (GABAerigic) balance in the
hippocampus. Alteration of neurogenesis by
in utero exposure of mice with mitotic
inhibitors also leads to increased vulnerability
to seizures in postnatal life, suggesting that
alteration in expansion of clusters of neuro-
progenitor cells can alter the excitability of
the developed brain (Paredes et al. 2006). In
the present study the in ovo exposure of DA
precedes both waves of anamniotic neuro-
genesis, indicating targeted mechanisms for
DA toxicity in rodents may also be activated
in the zebraﬁsh.
The in utero effects of DA are not limited
to seizure response but also extend to memory
and learning behaviors. Persistent effects on
learning and memory have been examined in
rats treated with DA in utero on GD13 (Levin
et al. 2005). DA led to a normalization of sex-
based differences that occur in radial-arm maze
testing. Additionally, when the rats were
exposed to the amnestic drug scopolamine,
animals injected with DA in utero showed sig-
nificant impairment in response time. These
results indicate that prenatal exposure to DA in
rats gives rise to a persistent effect of decreased
cognitive reserves. By contrast, rats exposed to
DA on PD0 and tested as juveniles and adults
did not show the above deﬁcits in learning and
cognitive reserve, but lesser effects were mani-
fested in hypoactivity (Levin et al. 2006).
Given that the peak in neurogenesis is com-
plete by birth in rats, these data suggest that
this window represents the most susceptible
time frame for DA toxicity.
It is possible that in ovo exposure to DA
in zebrafish may also provide a means to
PTZ induced seizures in DA-exposed zebrafish
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Figure 5. Duration of time spent in a strongly mobile state (mean ± SE) after exposure to PTZ. 
Values significantly greater than vehicle: *p < 0.05, **p < 0.01, and #p < 0.001. Values significantly lower than vehicle:  
##p < 0.05, and †p < 0.01.
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memory and cognitive reserve. DA effects on
seizure activity and memory appear to share
common pathways gated by the dentate gran-
ule cells of the hippocampus (Ramsdell 2007).
Development of the region structurally corre-
sponding to the hippocampus (lateral pallium)
in the zebrafish differs morphologically but
still appears to retain the functionality for spa-
tial memory (Rodriguez et al. 2002). Indeed,
adult zebrafish have been used in memory
studies and increasingly more behavioral stud-
ies with specially designed mazes and behav-
ioral monitoring software (Levin and Chen
2004). Adult zebraﬁsh are sensitive to persis-
tent adverse cognitive effects caused by
developmental exposure to the pesticide chlor-
pyrifos (Levin et al. 2004), much in the same
way as rats. Their work, like the present study,
demonstrated that zebrafish can replicate a
fetal exposure manifesting into adult disease.
The well-recognized attributes of zebraﬁsh for
developmental studies afford new opportun-
ties to investigate the role of DA and other
environmental toxicants that may contribute
to a fetal basis for adult disease.
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